Etonogestrel-releasing subdermal implant for adolescents in the postpartum period: a randomized controlled trial

Project: Research project


Adolescents who receive the subdermal contraceptive implant in the immediate postpartum period, before leaving the hospital after delivery, will be more likely to be using a long-term contraceptive at 1 year postpartum than adolescents who receive the subdermal implant at 6 weeks postpartum.
The overall objective of this study is to investigate immediate postpartum insertion of the etonogestrel-releasing subdermal contraceptive implant compared to placement at the traditional postpartum visit.
This is a prospective study comparing two groups of 48 adolescent women each. The intervention group will receive a subdermal implant postpartum, prior to discharge from the hospital. The control group will receive a subdermal implant at the usual 6 week postpartum clinic visit. During prenatal care, participants will be consented and screened for enrollment. After delivery, these women will be assessed and consented for enrollment into the study. Women who consent for enrollment will be randomized. Women will be followed up at 3 months, 6 months, 9 months, and 1 year after subdermal implant insertion. At each follow up, women will be assessed for continuation of and satisfaction with this method of contraception.
Effective start/end date7/1/127/31/14


  • American Congress of Obstetrians and Gynocologists (ACOG)


Postpartum Period
Randomized Controlled Trials
Contraceptive Agents
Prenatal Care
Ambulatory Care
Prospective Studies
Control Groups